Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

14 mai 2026 07h00 HE | Source: Cyclarity Therapeutics

Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions

Safe excretion of 7KC, a core driver of plaque associated with heart disease, stroke, inflammation, and age-related diseases, in humans suggests medicine could move beyond slowing heart disease to...
07 janv. 2025 09h00 HE | Source: Cyclarity Therapeutics

Cyclarity Therapeutics Secures Approval for First-in-Human Clinical Trial

NOVATO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cyclarity Therapeutics is pleased to announce regulatory approval to begin its first-in-human clinical trial. The trial will be conducted at CMAX,...
17 oct. 2023 18h04 HE | Source: Cyclarity Therapeutics

Cyclarity Therapeutics Announces Clinical Advisory Board

Cyclarity Therapeutics announce Clinical Advisory Board